Pfizer shines on receiving approval to sell Pfizer Animal Pharma

09 Nov 2012 Evaluate

Pfizer is currently trading at Rs. 1153.00, up by 18.90 points or 1.67% from its previous closing of Rs. 1134.10 on the BSE.

The scrip opened at Rs. 1145.00 and has touched a high and low of Rs. 1162.95 and Rs. 1145.00 respectively.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 1410.00 on 23-Apr-2012 and a 52 week low of Rs. 1071.55 on 30-Dec-2011.

Last one week high and low of the scrip stood at Rs. 1165.00 and Rs. 1130.00 respectively. The current market cap of the company is Rs. 3,440.00 crore.

The promoters holding in the company stood at 70.75% while Institutions and Non-Institutions held 9.44% and 19.81% respectively.

Pfizer has received an approval for the sale of its wholly owned subsidiary Pfizer Animal Pharma to Pfizer Animal Health India, a 100% indirect subsidiary of Pfizer Inc., USA for a consideration of Rs 471.60 crore.

The board at its meeting held on November 08, 2012 has approved for the same. Further, the above is however subject to receipt of prior regulatory approvals.

Pfizer manufactures prescription drugs such as Viagra, Lyrica, Viagra, Dolonex Gel, Ponstan, Citralka Liquid, and many more. Its first production unit was set up at Darukhanna in Mumbai.

Pfizer Share Price

5222.05 92.95 (1.81%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.